is in line with the reported worldwide epidemiologic trend for PsOCitation9 and may reflect improved overall survival of patients with PsO or, considering we used an insurance database, more patients accessing treatment, potentially prompted by new treatment optionsCitation38,Citation39. ...
Understanding IL-17 Therapies: Treatment Considerations, Rapid Response, and Impact on Plaque Psoriasis LocationPodcasts The Cutaneous Connection: An Inside Look of the Inclusive Atlas The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics The Cutaneous Connection: Episode 30- Impa...
Although several anticytokine antibodies and inhibitors are available for the treatment of psoriasis, more effective or better-tolerated alternatives would be of interest. In their article in the Journal of Investigative Dermatology , Michiels etal. (2021) propose a new strategy that targets an ...
Chinese medicine has many dosage forms for local treatment, such as ointment, liquid medicine and so on. The CM in the earliest literature on the treatment of psoriasis in China is a potion made ofMylabrisand others [7]. Up to now, there are more and more kinds of medicines for local ...
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies. Rheumatol. Int. 36, 603–612 (2016). Article CAS PubMed PubMed Central Google Scholar Mease, P. J. et al. Brodalumab, an anti-IL17RA monoclonal...
and increasing factors such as temperature and diet in experimental modeling may be a promising new field. Moreover, because the lung is related to body fluid regulation, it seems to be a good direction to connect them with the research of lung. In terms of treatment, the use of prescriptio...
Zerbinati N, Portale S, Palmieri B, Rottigni V, Iannitti T. A preliminary study to assess the efficacy of a new UVA1 laser for treatment of psoriasis. Photomed Laser Surg. 2012;30:610–4. ArticleGoogle Scholar Download references
August 4th 2021 Psoriasis as an Inflammatory Disease, and What’s Changed Over Time Continuing Medical EducationView All February 28th 2025 Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care 1.5 Credits / Dermatology, Immunology February 28th 2025 Adv...
Ali Khan et al (2023) noted that melasma is a chronic relapsing skin condition; laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) enhances the effectiveness of laser therapy in melasma is still unclear. With recent studies yielding different...
g. secukinumab have been approved19. With bimekizumab, a new biological for dual neutralization of IL-17A and IL-17F has recently been introduced to the market of therapeutic antibodies for PSO treatment20. Still, the development of new drugs and therapeutic compounds is of interest to cope ...